Handbook of Dialysis Therapy: First South Asia Edition

Rs. 795
  • Authors: Allen R. Nissenson, Richard E. Fine
  • ISBN: 9788131248904
  • Publisher: Elsevier Science Publishing
  • Publication Date: January 01, 2017
  • Format: Paperback – 1178 pages
  • Language: English

SKU 9788131248904 Category Tag


Share
Description

Providing practical, immediately useful guidelines that can be applied directly to patient care, Handbook of Dialysis Therapy is a must-have resource for all dialysis caregivers. This new edition has been updated with the latest cutting-edge technology, dialysis techniques, and complications related to various diseases for both pediatric and adult patients. In-depth yet concise, it explains complex dialysis concepts through abundant diagrams, photos, line drawings, and tables, while its readable hands-on approach allows for quick review of key information.

Key Features
  • Presents the practice-proven experience of top experts in the field of dialysis treatment.
  • Offers dialysis guidance for both adult and pediatric patients in one convenient source.
  • Features a readable hands-on approach, allowing you to quickly review the complicated concepts of dialysis.
  • Includes helpful annotated bibliography lists in each section for further in-depth research on any subject.
  • Explains complex dialysis concepts through abundant diagrams, photos, line drawings, and tables.
Table of Contents
  1. Section 1: Demographics
    1. C H A P T E R 1 Demographics of the End-Stage Renal Disease Patient
  2. Section 2: Vascular Access for Hemodialysis
    1. C H A P T E R 2 Vascular Access for Hemodialysis in Adults
    2. C H A P T E R 3 Central Venous Access for Hemodialysis
    3. C H A P T E R 4 Noninfectious Complications from Vascular Access
    4. C H A P T E R 5 Infectious Complications from Vascular Access
    5. C H A P T E R 6 Surveillance for Arteriovenous Access
    6. C H A P T E R 7 Interventional Nephrology
    7. C H A P T E R 8 Cannulation of Hemodialysis Vascular Access: Science and Art
  3. Section 3: Peritoneal Access Devices
    1. C H A P T E R 9 Peritoneal Access Devices, Placement Techniques, and Maintenance
  4. Section 4: Mechanical Aspects of Dialysis
    1. C H A P T E R 1 0 Water Treatment Equipment for In-Center Hemodialysis
    2. C H A P T E R 1 1 Methods and Complication of Dialyzer Reuse
    3. C H A P T E R 1 2 Dialysate Composition
    4. C H A P T E R 1 3 Safety Monitors in Hemodialysis
    5. C H A P T E R 1 4 Methods of Hemodialysis Anticoagulation
  5. Section 5: Home Dialysis
    1. C H A P T E R 1 5 Home Preparation and Installation for Home Hemodialysis
    2. C H A P T E R 1 6 Peritoneal Dialysis Cyclers and Other Mechanical Devices
  6. Section 6: Dialyzers
    1. C H A P T E R 1 7 Selecting a Dialyzer: Technical and Clinical Considerations
  7. Section 7: Adequacy of Dialysis
    1. C H A P T E R 1 8 Uremic Toxicity C H A P T E R 1 9 Urea Kinetic Modeling for Guiding Hemodialysis Therapy in Adults
    2. C H A P T E R 2 0 The Dialysis Prescription
  8. Section 8: Improving Outcomes in Dialysis Patients
    1. C H A P T E R 2 1 Improving Outcomes for End-Stage Renal Disease Patients: Shifting the Quality Paradigm
    2. C H A P T E R 2 2 Quality, Safety, Accountability, and Medical Director Responsibilities
    3. C H A P T E R 2 3 Initiation of Dialysis Therapy
  9. Section 9: Complications During Hemodialysis
    1. C H A P T E R 2 4 Common Clinical Problems During Hemodialysis
    2. C H A P T E R 2 5 Arrhythmias in Hemodialysis Patients
    3. C H A P T E R 2 6 Prevention and Therapeutic Management of Bleeding in Dialysis Patients
  10. Section 10: Alternative Hemodialytic Techniques
    1. C H A P T E R 2 7 Hemofiltration/Hemodiafiltration
    2. C H A P T E R 2 8 Convective Renal Replacement Therapies for Acute Kidney Injury
    3. C H A P T E R 2 9 Anticoagulation for Continuous Renal Replacement Therapy (CRRT)
    4. C H A P T E R 3 0 Wearable Artificial Kidney
  11. Section 11: Peritoneal Dialysis: Clinical Practice
    1. C H A P T E R 3 1 Determination of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis Prescriptions
    2. C H A P T E R 3 2 Peritoneal Dialysis Solutions
    3. C H A P T E R 3 3 Lymphatics, Peritoneal Fluid Losses, and Peritoneal Dialysis
  12. Section 12: Peritoneal Dialysis: Infectious Complications
    1. C H A P T E R 3 4 Abnormalities of Host Defense Mechanisms During Peritoneal Dialysis
    2. C H A P T E R 3 5 Peritoneal Catheter Exit-Site and Tunnel Infections
    3. C H A P T E R 3 6 Peritonitis in Peritoneal Dialysis
  13. Section 13: Peritoneal Dialysis: Noninfectious Complications
    1. C H A P T E R 3 7 Peritoneal Membrane Dysfunction: Inadequate Solute Removal, Ultrafiltration Failure and Encapsulating Peritoneal Sclerosis
    2. C H A P T E R 3 8 Abdominal Catastrophes, Peritoneal Eosinophilia, and Other Unusual Events in Peritoneal Dialysis
    3. C H A P T E R 3 9 Metabolic Complications of Peritoneal Dialysis
    4. C H A P T E R 4 0 Abdominal Hernias in Continuous Ambulatory Peritoneal Dialysis
    5. C H A P T E R 4 1 Dialysate Leaks
    6. C H A P T E R 4 2 Hydrothorax and Peritoneal Dialysis
  14. Section 15: Acid-Base Homeostasis
    1. C H A P T E R 4 3 Acid-Base Homeostasis in Dialysis
  15. Section 16: Nutritional Management of Dialysis Patients
    1. C H A P T E R 4 4 Nutritional Management of Hemodialysis Patients
    2. C H A P T E R 4 5 Intradialytic Parenteral Nutrition and Intraperitoneal Nutrition
    3. C H A P T E R 4 6 Nutritional Management in Peritoneal Dialysis
    4. Section 17: Gastrointestinal Disease
    5. C H A P T E R 4 7 Liver Disease and Gastrointestinal Disorders in Dialysis Patients
  16. Section 18: The HIV-Infected Patient
    1. C H A P T E R 4 8 Care of the HIV-Infected Dialysis Patient
  17. Section 19: Anemia and Epoetin Use
    1. C H A P T E R 4 9 Use of Erythropoietic-Stimulating Agents in Hemodialysis Patients
    2. C H A P T E R 5 0 Anemia in Patients and End-Stage Kidney Disease
    3. C H A P T E R 5 1 Iron Use in End-Stage Renal Disease
    4. C H A P T E R 5 2 Resistance to Erythropoiesis Stimulatin Agent (ESA) Treatment Section 20: Cardiovascular Disease
    5. C H A P T E R 5 3 The Challenges of Blood Pressure Control in Dialysis Patients
    6. C H A P T E R 5 4 Management of Ischemic Heart Disease, Heart Failure, and Pericarditis in Hemodialysis Patients
    7. C H A P T E R 5 5 Avoidance and Treatment of Cardiovascular Disease in Dialysis
  18. Section 21: Metabolic Abnormalities
    1. C H A P T E R 5 6 Management of Dyslipidemia in Long-Term Dialysis Patients
    2. C H A P T E R 5 7 Abnormalities of Thyroid Function in Chronic Dialysis Patients
    3. C H A P T E R 5 8 Metabolic Abnormalities: Evaluation of Sexual Dysfunction
  19. Section 22: Uremic Osteodystrophy
    1. C H A P T E R 5 9 Chronic Kidney Disease-Mineral and Bone Disorder
    2. C H A P T E R 6 0 Phosphate Management in Patients With End-Stage Renal Disease
    3. C H A P T E R 6 1 Use of Vitamin D Sterols and Calcimimetics in Patients of ESRD
    4. C H A P T E R 6 2 Parathyroidectomy
  20. Section 23: Acquired Cystic Kidney Disease
    1. C H A P T E R 6 3 Acquired Cystic Kidney Disease
  21. Section 24: Diabetes
    1. C H A P T E R 6 4 End-Stage Renal Failure in the Diabetic Patient
  22. Section 25: Drug Use in Uremia
    1. C H A P T E R 6 5 Principles of Drug Use in Dialysis Patients
    2. C H A P T E R 6 6 Medication Management
  23. Section 26: Rehabilitation and Psychosocial Issues
    1. C H A P T E R 6 7 Physical Activity, Function, and Exercise-Based Rehabilitation for Dialysis Patients
    2. C H A P T E R 6 8 Physical, Psychosocial, and Vocational Rehabilitation of Adult Dialysis Patients
    3. C H A P T E R 6 9 Ethical Considerations in the Care of Dialysis Patients
    4. C H A P T E R 7 0 Psychosocial Issues in Dialysis Patients
    5. C H A P T E R 7 1 Care of Elderly Dialysis and End-Stage Renal Disease Patients
  24. Section 27: Pediatric Dialysis
    1. C H A P T E R 7 2 Vascular Access in Children C H A P T E R 7 3 Infant Hemodialysis
    2. C H A P T E R 7 4 Urea Kinetic Modeling for Hemodialysis Prescription in Children
    3. C H A P T E R 7 5 Hemodiafiltration in Children: An Ultrapure Complete Blood Purification
    4. C H A P T E R 7 6 Home Hemodialysis in Children
    5. C H A P T E R 7 7 Anticoagulation in Children Undergoing Hemodialysis
    6. C H A P T E R 7 8 Peritoneal Catheter Placement in Children
    7. C H A P T E R 7 9 Prescribing Peritoneal Dialysis in Children
    8. C H A P T E R 8 0 Nutritional Management of Children Undergoing Peritoneal Dialysis
    9. C H A P T E R 8 1 Infant and Neonatal Peritoneal Dialysis
    10. C H A P T E R 8 2 Dialysis in Inborn Errors of Metabolism
    11. C H A P T E R 8 3 Neurocognitive Development in Children Undergoing Dialysis
    12. C H A P T E R 8 4 Growth in Children with End-Stage Renal Disease
    13. C H A P T E R 8 5 Adequacy of Peritoneal Dialysis/Assessing Peritoneal Function in Pediatric Patients
    14. C H A P T E R 8 6 Continuous Renal Replacement Therapy in Pediatric Patients
    15. C H A P T E R 8 7 Prevention and Treatment of Bone Disease in Pediatric Dialysis Patients
    16. C H A P T E R 8 8 Management of Anemia in Children Undergoing Dialysis
    17. C H A P T E R 8 9 Assessing Quality of Life in Pediatric Patients Undergoing Dialysis
    18. C H A P T E R 9 0 Immunization in Children Undergoing Dialysis
    19. C H A P T E R 9 1 Prevention and Treatment of Cardiovascular Complications in Children Undergoing Dialysis
    20. C H A P T E R 9 2 Surgery in Children with End-Stage Renal Disease
    21. C H A P T E R 9 3 Infectious Complications in Children Undergoing Dialysis
    22. C H A P T E R 9 4 Adherence and Transition in the Pediatric Dialysis Patient
  25. Section 28: The Pregnant Patient
    1. C H A P T E R 9 5 Pregnancy in Dialysis Patients
  26. Section 29: Miscellaneous Areas of Clinical Importance
    1. C H A P T E R 9 6 Treatment of Poisoning with Extracorporeal Methods
    2. C H A P T E R 9 7 Preventative Care in End-Stage Renal Disease
    3. C H A P T E R 9 8 Application of Telemedicine to Patients With End-Stage Renal Disease
Authors Biography

Allen R. Nissenson, Emeritus Professor of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, Los Angeles, CA

Richard E. Fine, Professor Emeritus, Department of Biochemistry, Boston University School of Medicine, Boston, MA, United States

Additional information
Weight0.648 kg
Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.